Measurement of Credit Exposure of Derivative Products
DBOD.
No. BP. BC. 48 - 21.03.054 - dated 13th December 2002
Please refer to paragraph B.2 our circular
DBOD.No.BP.BC.116/21.04.048/ 2000-2001 dated May 2, 2001 on credit exposure to
individual / group borrowers. It was mentioned therein that at present,
derivative products such as forward
Rate Agreements (FRAs) and Interest Rate Swaps (IRSs) are captured for computing
exposure by applying the conversion factors to notional principal amounts as per
the original exposure method. It was also indicated that, effective from April
1, 2003, in addition to reckoning non-fund based limits at 100 per cent, banks
should also include forward contract in foreign exchange and other derivative
products at their replacement cost value in determining individual / group
borrower exposure. The methodology to be adopted by banks for arriving at the
replacement cost value is given below.
2.
As per the Basle Committee on Banking Supervision�s International
Convergence of Capital Measurement and Capital Standards, 1988, there are two
methods to assess the exposure on account of credit risk in derivative products,
viz. (i) Original Exposure Method, and (ii) Current
Exposure Method.
2.1 Under the Original Exposure Method, credit exposure is
calculated at the beginning of the derivative transaction by multiplying the
notional principal amount with a conversion factor. In order to arrive at the
credit equivalent amount using the Original Exposure Method, a bank would apply
the following credit conversion factors to the notional principal amounts of
each instrument according to the nature of the instrument and its original
maturity:
Original
Maturity
|
Conversion
Factor to be applied on Notional Principal Amount
|
Interest
Rate Contract
|
Exchange
Rate Contract
|
Less
than one year
|
0.5%
|
2.0 %
|
One
year and less than two years
|
1.0%
|
5.0 % (2
% + 3 %)
|
For
each additional year
|
1.0%
|
3.0 %
|
2.2
The other method (Current Exposure Method) to assess the exposure on
account of credit risk on interest rate and exchange rate derivative contracts
is to calculate periodically the current replacement cost by marking these
contracts to market, thus capturing
the current exposure without any need for estimation and then adding a factor
(�add-on�) to reflect the potential future exposure over the remaining life
of the contract. Therefore, in order to calculate the credit exposure equivalent
of off-balance sheet interest rate and exchange rate instruments under current
exposure method, a bank would sum:
(i)
the total replacement cost (obtained by �marking to market�) of all
its contracts with positive value (i.e. when the bank has to receive money from
the counterparty), and
(ii)
an amount for potential future changes in credit exposure calculated on
the basis of the total notional principal amount of the contract multiplied by
the following credit of conversion factors according to the residual maturity:
Residual
Maturity
|
Conversion
Factor to be applied on Notional Principal Amount
|
Interest
Rate Contract
|
Exchange
Rate Contract
|
Less
than one year
|
Nil
|
1.0 %
|
One
year and over
|
0.5%
|
5.0 %
|
2.3 Banks should mark to market the derivative products at
least on a monthly basis and they may follow their internal methods of
determining the marked to market value of the derivative products.
2.4 Banks would not be required to calculate potential credit
exposure for single currency floating / floating interest rate swaps. The credit
exposure on these contracts would be evaluated solely on the basis of their
mark-to-market value.
3. Banks are encouraged to follow the Current
Exposure Method, which is an accurate method of measuring credit exposure in a
derivative product. In case a bank is not in a position to adopt the Current
Exposure Method, it may follow the Original Exposure Method. However, its
endeavour should be to move over to Current Exposure Method in course of time.
4. Banks are advised to adopt, effective from
April 1, 2003, either of the above two methods, consistently for all derivative
products, in determining individual / group borrower exposure.
5.
Please acknowledge receipt.
|